Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | LY2275796 |
Trade Name | |
Synonyms | ISIS 183750|LY-2275796|LY 2275796 |
Drug Descriptions |
LY2275796 is an antisense oligonucleotide targeted against eukaryotic initiation factor 4E (eIF-4E), which results in decreased eIF-4E expression and potentially leads to reduced growth of eIF-4E-expressing tumors (PMID: 17786246, PMID: 21831956, PMID: 27194579). |
DrugClasses | Antisense Therapy 13 |
CAS Registry Number | NA |
NCIT ID | C95740 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY2275796 | LY2275796 | 0 | 0 |